By using this site you agree to our use of cookies. Please refer to our privacy policy for more information. Close
Detection of PCV1 Virus Caused Temporary Suspension of Rotarix Vaccine
- Date: March 22, 2010
- Source: Admin
Compliance Webinars | Virtual Seminars for Professionals
Recently, an independent U.S. academic research team found the presence of DNA from porcine circovirus 1 (PCV1) in Rotarix which can cause diarrhea as it is contaminated with an apparently harmless pig virus. Although it has been proved by several tests that PCV1 does not cause illness in humans or other animals, still FDA wants to learn more about PCV1 in order to ensure a better safety of the patients. Clearing the air of safety issue, in a media briefing, FDA Commissioner Margaret Hamburg stressed the fact that PCV1 is a virus, and certainly not a food safety issue.
Follow-up tests done by GSK and FDA scientists confirmed the presence of the viral since the early stages of development of the vaccine. However, preliminary testing by both the academic researchers and FDA scientists of another licensed vaccine against rotavirus infection, RotaTeq, has not detected components of PCV1.
Rotarix and RotaTeq are given by mouth to young infants to prevent rotavirus disease.The FDA licensed RotaTeq in 2006 and Rotarix in 2008. Most children vaccinated in the US received RotaTeq.
FDA will inform health practitioners, patients and providers as soon as it gets any update on the vaccine and will also continue to communicate with the World Health Organization and counterpart regulatory agencies in other countries.
Source:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm205625.htm
http://biopharminternational.findpharma.com/... http://www.reuters.com/a...Health+News%29
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
By: Miles HutchinsonAdd to CartPrice: $249
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
Add to CartSan Francisco, CA | Aug 6-7, 2020
-
Add to CartVirtual Seminar | Jul 16-17, 2020
-
Add to CartVirtual Seminar | Jun 18-19, 2020
-
Add to CartLos Angeles, CA | Aug 20-21, 2020
-
Add to CartVirtual Seminar | Jul 16-17, 2020
-
Add to CartVirtual Seminar | Jun 25-26, 2020
-
Add to CartVirtual Seminar | Jun 10, 2020
-
Add to CartVirtual Seminar | Jun 3-4, 2020
-
Add to CartVirtual Seminar | Jul 6-7, 2020
-
Add to CartSan Francisco, CA | Oct 22-23, 2020
-
Add to CartVirtual Seminar | Jul 9-10, 2020
-
Add to CartVirtual Seminar | Jun 3-4, 2020
-
Add to CartVirtual Seminar | June 3-4, 2020
-
Add to CartMiami, FL | Jul 29-31, 2020
-
Add to CartVirtual Seminar | Jun 17, 2020
-
Provider: ANSIAdd to CartPrice: $142
- Add to Cart
- Add to Cart
- Add to Cart
-
Provider: ANSIAdd to CartPrice: $120
-
Provider: ANSIAdd to CartPrice: $250
-
Provider: SEPTAdd to CartPrice: $299
- Add to Cart
-
Provider: Quality-Control-PlanAdd to CartPrice: $37
- Add to Cart
-
Provider: At-PQCAdd to CartPrice: $397
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart







